Results 281 to 290 of about 34,144 (356)

Prolonged Prophylactic Antibiotics Based on Preoperative Bile Culture Reduce Surgical Site Infections After Pancreaticoduodenectomy Following Preoperative Biliary Drainage: A Propensity‐Matched Analysis

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 1, Page 197-210, January 2026.
ABSTRACT Objective The optimum duration of prophylactic antibiotics after pancreaticoduodenectomy following preoperative biliary drainage to prevent surgical site infections remains controversial. We evaluate whether a prolonged course of prophylactic antibiotics reduces surgical site infection after pancreaticoduodenectomy following biliary drainage ...
Kyohei Matsumoto   +9 more
wiley   +1 more source

Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right‐Sided Major Hepatectomy

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 1, Page 229-240, January 2026.
Sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) significantly improves both the volume and function of the future remnant liver (FRL) compared to PVE alone. In this study, the FRL regeneration rates for volume and function were markedly higher and faster in the PVE–HVE group, with no differences in surgical outcomes ...
Thanh Tung Lai   +9 more
wiley   +1 more source

Essential Updates 2024/2025: History, Pathogenesis, Definition, Prevention, and Management of Small‐for‐Size Syndrome in Living‐Donor Liver Transplantation

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 1, Page 35-41, January 2026.
ABSTRACT Although living‐donor liver transplantation (LDLT) has become the standard treatment for end‐stage liver disease, one of its major challenges is small‐for‐size syndrome (SFSS). SFSS is characterized by severe icterus and intractable ascites, although the severity of the condition can vary.
Toru Ikegami   +6 more
wiley   +1 more source

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas

open access: yesAmerican Journal of Hematology, Volume 101, Issue 1, Page 110-128, January 2026.
ABSTRACT The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues.
Harald Stein, Brunangelo Falini
wiley   +1 more source

Delayed‐Onset Infected Perirenal Hematoma Following Trauma: A Case Report

open access: yesAcute Medicine &Surgery, Volume 13, Issue 1, January/December 2026.
Delayed‐onset infected perirenal hematoma should be considered in elderly patients presenting with systemic symptoms after minor blunt trauma. ABSTRACT Background Perirenal hematomas are commonly observed in patients with renal trauma; however, secondary infections are uncommon and often underdiagnosed.
Yuta Nakamura   +3 more
wiley   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

open access: yesArthritis &Rheumatology, Volume 78, Issue 1, Page 12-25, January 2026.
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen   +2 more
wiley   +1 more source

Fulminant Hepatic Failure in Dengue Infection: Two Survivors From a Resource‐Limited Outbreak in Sudan

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Dengue is a leading cause of viral hemorrhagic fever globally, with hepatic involvement being common but usually mild. Rarely, dengue can progress to fulminant hepatic failure, a life‐threatening complication requiring prompt recognition especially in resource‐limited settings.
Mohamed Bushra Alajab   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy